Immuneering (IMRX) Operating Leases (2020 - 2026)
Immuneering (IMRX) recorded Operating Leases of $3.2 million in Q2 2026, down 11.8% from $3.63 million a year earlier and down 3.4% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Immuneering reported Operating Leases of $3.43 million, down 10.4% from FY2024.
- Annual Operating Leases has declined for four straight years, though with a five-year compound annual growth rate of 44.5% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $3.82 million in FY2024 (-8.1%), $4.16 million in FY2023 (-6.7%), $4.46 million in FY2022 (-12.3%) and $5.09 million in FY2021 (+834.5%).
- The Q2 2026 figure is the lowest quarterly Operating Leases since Q3 2021.
- On a year-over-year basis, Operating Leases has declined for 15 consecutive quarters, with an average decline of 9.6% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 842.5% in Q3 2022, against a decline of 12.3% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.32 million (Q1 2026), $3.43 million (Q4 2025) and $3.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Immuneering | 269.14 Mn | 269.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | 4.16 Mn |
| Sep 30, 2023 | 4.24 Mn |
| Jun 30, 2023 | 4.31 Mn |
| Mar 31, 2023 | 4.38 Mn |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 4.64 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Sep 30, 2021 | 481,965.00 |
API Access
Immuneering Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();